Latest News - IQVIA
Top Corporates Hub
IQVIA
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 27% Discount?
23.12.2025 12:00
Key Insights The projected fair value for IQVIA Holdings is US$309 based on 2 Stage Free Cash Flow to Equity IQVIA...
IQVIA: Increasingly Indispensable In Drug Development
11.12.2025 13:56
Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock upside.
Those who invested in IQVIA Holdings (NYSE:IQV) five years ago are up 34%
05.12.2025 12:00
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...
Is IQVIA Holdings Stock Outperforming the S&P 500?
04.12.2025 03:32
IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly bullish on the stock’s prospects.
IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform
02.12.2025 13:00
RESEARCH TRIANGLE PARK, N.C., December 02, 2025--IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic collaboration with Amazon Web Services (AWS), naming AWS as IQVIA’s Preferred Agentic Cloud Provider. The partnership, revealed at AWS re:Invent, is a major step in the digital transformation of healthcare and life sciences, aiming to revolutionize cl
Is Now An Opportune Moment To Examine IQVIA Holdings Inc. (NYSE:IQV)?
27.11.2025 11:00
Let's talk about the popular IQVIA Holdings Inc. ( NYSE:IQV ). The company's shares received a lot of attention from a...
3 Profitable Stocks We Steer Clear Of
18.11.2025 04:34
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
BMO Capital Initiates Coverage of IQVIA Holdings (IQV) with Outperform Recommendation
13.11.2025 12:03
3 Inflated Stocks with Warning Signs
13.11.2025 04:35
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
07.11.2025 03:32
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.
US$245 - That's What Analysts Think IQVIA Holdings Inc. (NYSE:IQV) Is Worth After These Results
31.10.2025 10:36
Last week saw the newest third-quarter earnings release from IQVIA Holdings Inc. ( NYSE:IQV ), an important milestone...
IQV Q3 Deep Dive: Clinical Research Demand and AI Initiatives Drive Steady Growth
29.10.2025 05:31
Clinical research company IQVIA (NYSE: IQV) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s revenue to be around $16.2 billion, close to analysts’ estimates. Its non-GAAP profit of $3 per share was 0.8% above analysts’ consensus estimates.
IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say
29.10.2025 00:00
While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript
28.10.2025 13:52
IQVIA Holdings Inc. (NYSE:IQV) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDTCompany ParticipantsKerri Joseph - SVP of Investment Relation &...
IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates
28.10.2025 12:15
IQVIA (IQV) delivered earnings and revenue surprises of +1.35% and +0.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
IQVIA (NYSE:IQV) Beats Q3 Sales Expectations
28.10.2025 11:28
Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s revenue to be around $16.2 billion, close to analysts’ estimates. Its non-GAAP profit of $3 per share was 0.8% above analysts’ consensus estimates.